Clifford Chance advised Charme Capital Partners on the deal. Charme Capital Partners, a pan-European private equity firm, announced the acquisition of Centogene GmbH, a rare diseases...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here